Real-time enrollment status for this pulmonary disease, chronic obstructive clinical trial
Current Status
Recruiting
Checked: September 26, 2026 at 6:04 AM UTC
| NCT Number | NCT07759245 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Disease, Chronic Obstructive |
| Phase | PHASE2 |
| Target Enrollment | 606 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | September 25, 2026 (Yesterday) |
As of September 26, 2026: Clinical trial NCT07759245 is currently recruiting participants. This phase2 study for pulmonary disease, chronic obstructive is actively seeking new participants at 18 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07759245 is actively recruiting participants as of September 26, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07759245 was last updated Yesterday (September 25, 2026). HelloStudys verifies this status automatically.